1.
Am Heart J
; 206: 127-130, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30227941
RESUMO
Warfarin, a vitamin K antagonist, is associated with systemic vascular calcification. We evaluated whether rivaroxaban (a direct oral factor Xa inhibitor with no interaction with vitamin K) will slow the progression in coronary plaque volumes compared with warfarin in patients with nonvalvular atrial fibrillation using coronary computed tomography angiography.